Labshake search
Citations for Stemcell Technologies :
1 - 50 of 2034 citations for Human Hypoxia inducible factor 3 alpha HIF3A ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2022Quote: Hypoxia treatment of cells: Plated cells were placed in the interior of a hypoxia incubator chamber (STEMCELL technologies) and flushed with 95% Nitrogen (purity ...
-
bioRxiv - Neuroscience 2021Quote: ... TNF alpha (0.5ng/mL final concentration in PBS, human recombinant, Stemcell Tech) was added to half of the wells ...
-
bioRxiv - Cancer Biology 2019Quote: ... 20 ng/ml human recombinant epidermal growth factor (StemCell Technologies), 1% Penicillin/Streptomycin (Gibco ...
-
bioRxiv - Biochemistry 2023Quote: ... 10 ng/ml human epidermal growth factor (STEMCELL Technologies, 78006), 20 ng/mL basic fibroblast growth factor (STEMCELL Technologies ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 ng/ml Recombinant Human Glial-Derived Neurotrophic Factor (StemCell Technologies), 1 mM Dibutyryl-cAMP (PeproTech) ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 ng/ml Recombinant Human Brain-Derived Neurotrophic Factor (StemCell Technologies), 20 ng/ml Recombinant Human Glial-Derived Neurotrophic Factor (StemCell Technologies) ...
-
bioRxiv - Cancer Biology 2022Quote: ... 20 ng/ml human recombinant epidermal growth factor (STEMCELL Technologies, 78006.1), 10 ng/ml human recombinant basic fibroblast growth factor (STEMCELL Technologies ...
-
bioRxiv - Cancer Biology 2024Quote: ... 20 ng/ml human basic fibroblast growth factor (Stemcell Technologies, 78003), 2 μg/ml heparin (Stemcell Technologies ...
-
bioRxiv - Physiology 2021Quote: The EPO concentrations from 34 serum samples were determined using the Human Erythropoietin ELISA Kit from Stemcell Technologies. Briefly ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1) and 10 ng/mL human recombinant Epidermal Growth Factor (EGF ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1) and 10 ng/mL human recombinant Epidermal Growth Factor (EGF ...
-
bioRxiv - Bioengineering 2021Quote: ... 10 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1), and 10 ng/mL GDNF ...
-
bioRxiv - Bioengineering 2021Quote: ... 20 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), 10 ng/mL human recombinant Leukemia Inhibitory Factor (LIF ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/ml human recombinant basic fibroblast growth factor (STEMCELL Technologies, 78003.1), and 0.679 U/ml heparin (Sigma ...
-
bioRxiv - Cell Biology 2023Quote: ... Hypoxia exposed cultures were incubated in a gas-tight chamber (STEMCELL Technologies) filled with 3% O2 ...
-
bioRxiv - Cell Biology 2023Quote: ... The culture was then placed in an Hypoxia Incubator Chamber (StemCell Technology) and were equilibrated for 15 minutes with a continuous flux of 95% N2/5% CO2 gas ...
-
bioRxiv - Cancer Biology 2021Quote: ... supplemented with human recombinant epidermal growth factor (20ng/mL: STEMCELL Technologies, Cat#78006), basic fibroblast growth factor (20ng/mL ...
-
bioRxiv - Cancer Biology 2019Quote: ... 20 ng/mL Recombinant Human Epidermal Growth Factor (EGF) (StemCell Technologies, Cat 02633), 10 ng/mL Recombinant Human Basic Fibroblast Growth Factor (Bfgf ...
-
bioRxiv - Bioengineering 2021Quote: ... and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1) in RPMI 1640 for 2 days ...
-
bioRxiv - Bioengineering 2021Quote: ... and 10 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), and passaged using TrypLE™ Express Enzyme.
-
bioRxiv - Bioengineering 2021Quote: ... and 10 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), and passaged using TrypLE™ Express Enzyme.
-
bioRxiv - Bioengineering 2021Quote: ... and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1) for 2 days ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1), 20 ng/mL animal component-free human recombinant Glial Cell Derived Neurotrophic Factor (GDNF ...
-
bioRxiv - Cancer Biology 2022Quote: ... Hypoxic conditions were maintained in a Hypoxia Incubator Chamber (STEMCELL Technologies, Vancouver, Canada) for 24 hours at 94% N2 ...
-
bioRxiv - Immunology 2023Quote: ... cells were incubated for 6h in hypoxia incubator chamber (Stem cell Technologies, #27310) at 37°C and 1% CO2.
-
bioRxiv - Molecular Biology 2024Quote: ... cells growing at 60% confluence were transferred to a hypoxia chamber (STEMCELL technologies) which was purged with a gaseous mixture of 1% O2 ...
-
bioRxiv - Cancer Biology 2019Quote: ... 10 ng/mL Recombinant Human Basic Fibroblast Growth Factor (Bfgf) (StemCell Technologies, Cat 02634), 2 μg/mL Heparin (StemCell Technologies ...
-
bioRxiv - Developmental Biology 2022Quote: ... supplemented with 30 ng/mL human recombinant epidermal growth factor (rhEGF) (STEMCELL Technologies 78006) and filtered through a 40 μm filter (Fisherbrand™ 22-363-547 ...
-
bioRxiv - Neuroscience 2021Quote: ... integrated and inducible pure human cortical-like glutamatergic neurons (i3Ns) was completed in two weeks in BrainPhys media (STEMCELL Technologies, 05790) (Figure ...
-
bioRxiv - Immunology 2023Quote: ... Human Peripheral Blood Plasma (3%; Stem Cell Technologies), 3,3‘,5-Triiodo-L-thyronine (1 µM ...
-
bioRxiv - Immunology 2022Quote: ... and human B-cell activating factor (BAFF) in 80 mL StemCell medium A (StemCell Technologies) containing 1 μg/mL of cyclosporine A (Millipore-Sigma) ...
-
bioRxiv - Bioengineering 2021Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). On the following day ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). After sublethal conditioning of 9-12 weeks old Gaa−/− mice with 7.5 Gy gamma-irradiation (1.6 Gy/min ...
-
bioRxiv - Cancer Biology 2020Quote: ... Cell cultures were grown under hypoxic conditions using a Hypoxia Chamber (STEMCELL Technologies, Vancouver, Canada) at 37°C ...
-
bioRxiv - Neuroscience 2021Quote: ... The cell cultures were placed in a hypoxia incubation chamber (Stemcell Technologies; Vancouver, BC, Canada) filled with 95% N2 ...
-
bioRxiv - Developmental Biology 2021Quote: ... coated dishes at 37°C under hypoxia conditions (10% CO2/5%O2) in mTeSR1 (StemCell Technologies). These were passaged every 4-6 days with Accutase (#A6964 ...
-
bioRxiv - Bioengineering 2021Quote: ... 20 ng/mL animal component-free human recombinant Glial Cell Derived Neurotrophic Factor (GDNF, STEMCELL Technologies, 78139), 0.2% Chemically Defined Lipid Concentrate (Thermofisher ...
-
bioRxiv - Bioengineering 2021Quote: ... 20 ng/mL animal component-free human recombinant Glial Cell Derived Neurotrophic Factor (GDNF, STEMCELL Technologies, 78139), 0.2% Chemically Defined Lipid Concentrate (Thermofisher ...
-
Efficient Methods for Target Gene Manipulation in Haematopoietic Stem Cell Derived Human NeutrophilsbioRxiv - Cell Biology 2023Quote: ... medium was changed to SFEM II containing 10ng/mL recombinant human granulocyte colony stimulating factor (StemCell Technologies) and maintained in this medium until day 20 ...
-
bioRxiv - Pathology 2021Quote: Cell culture under hypoxic conditions was performed in a commercially available humidified hypoxia chamber (STEMCELL technologies, Cambridge, UK) in an incubator at 37°C ...
-
bioRxiv - Microbiology 2023Quote: ... Human NK cell or Human Monocyte CD14+ Isolation kits (STEMCELL Technologies), respectively ...
-
bioRxiv - Bioengineering 2023Quote: ... NGN2-inducible iPSCs were cultured in mTeSR Plus Medium (STEMCELL Technologies), whereas ASCL1-DLX2-inducible iPSCs were sustained in StemMACS iPS-Brew medium (Miltenyi Biotec) ...
-
bioRxiv - Biophysics 2021Quote: ... 05702) and media supplemented with 20ng/ml of human recombinant epithelial growth factor (EGF - STEMCELL Technologies, Cat. No. 78006). All cells were grown in a humidified incubator atmosphere at 37°C and 5% CO2 ...
-
bioRxiv - Microbiology 2021Quote: ... IFNα was quantified using the pan-IFNα ELISA kit (Stem Cell Technologies). IFNβ was quantified using human IFN-beta Quantikine ELISA kit (R&D Systems) ...
-
bioRxiv - Immunology 2020Quote: ... EasySep human CD4+ T cell enrichment kit and EasySep human CD8+ T cell enrichment kit (STEMCELL Technologies, Canada), respectively ...
-
bioRxiv - Bioengineering 2020Quote: ... A hypoxic environment was created by placing the cell culture vessels in a hypoxia incubator chamber (STEMCELL Technologies, Cambridge MA), which was then filled with a gas mixture containing 2% O2 ...
-
bioRxiv - Cell Biology 2020Quote: ... Cells were suspended in Hanks Balanced Salt Solution (HBSS) supplemented with 5% human serum and 1.5 µg/mL anti-human CD32 antibody (Clone IV.3; STEMCELL Technologies) and then stained with designated antibodies for 1-2 hours on ice prior to sorting on a Becton Dickinson FACSAria™ Fusion or FACSAria™ III sorter ...
-
bioRxiv - Bioengineering 2021Quote: ... and 25 ng/mL BMP4 with 50 ng/mL human recombinant Vascular Endothelial Growth Factor 165 (VEGF-165, STEMCELL Technologies, 78073) for 2 days ...
-
bioRxiv - Developmental Biology 2023Quote: ... Embryos were incubated at 37°C and 5% CO2 in normoxia and in pre-equilibrated human IVC1 supplemented with 50ng/mL Insulin Growth Factor-1 (IGF1) (78078, STEMCELL Technologies) under mineral oil for 1-4h to allow for recovery ...
-
bioRxiv - Bioengineering 2022Quote: ... Alpha MEM with nucleosides (StemCell Technologies, Vancouver, Canada) were purchased for cell culture purposes ...